Inventor
END DAVID WILLIAM
US13 patents
⚠️ This page may combine multiple inventors who share the name “END DAVID WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
10 patentsUS5968952AOct 19, 1999
Farnesyl transferase inhibiting 2-quinolone derivatives
JANSSEN PHARMACEUTICA NV95 citations97
US6743805B2Jun 1, 2004
Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation
JANSSEN PHARMACEUTICA NV59 citations94
US6734194B2May 11, 2004
Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation
JANSSEN PHARMACEUTICA NV67 citations94
US6451812B1Sep 17, 2002
Farnesyl protein transferase inhibitors for treating arthropathies
JANSSEN PHARMACEUTICA NV92 citations94
US6365600B1Apr 2, 2002
(Imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
JANSSEN PHARMACEUTICA NV40 citations94
US6838467B2Jan 4, 2005
Dosing regimen
JANSSEN PHARMACEUTICA NV56 citations92
US7253183B2Aug 7, 2007
Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation
JANSSEN PHARMACEUTICA NV17 citations91
US6545020B1Apr 8, 2003
Farnesyl Protein transferase inhibitors with in vivo radiosensitizing properties
JANSSEN PHARMACEUTICA NV56 citations84
US7511061B2Mar 31, 2009
Triazoles as farnesyl transferase inhibitors
JANSSEN PHARMACEUTICA NV2 citations61
US7592356B2Sep 22, 2009
Triazoles as farnesyl transferase inhibitors
JANSSEN PHARMACEUTICA NV0 citations51